MedTrace Logo

Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin Coagulum

NCT02802995 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-10-26

No results posted yet for this study

Summary

The aim of this study is to

* To evaluate the safety and tolerability of Platelet Rich plasma(PRP)/Thrombin mixture in treating chronic venous ulcers
* To evaluate efficacy of PRP/Thrombin mixture in treating chronic venous ulcers

Conditions

  • Stasis Ulcer

Interventions

DRUG

PRP/thrombin mixture

Mixture of platelet rich plasma and thrombin applied topically on the wound surface

Sponsors & Collaborators

  • University of Witwatersrand, South Africa

    lead OTHER

Principal Investigators

  • Johnny Mahlangu, MBBCH, MMed · Univeristy of the Witwatersrand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02802995 on ClinicalTrials.gov